|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||

1 Whitehead Institute, 9 Cambridge Center, Cambridge, MA 02142, USA
2 Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA
* These authors contributed equally to this work
Author for correspondence (e-mail: daley{at}wi.mit.edu)
Accepted August 14, 2001
Embryonic stem (ES) cells differentiate into multiple hematopoietic lineages during embryoid body formation in vitro, but to date, an ES-derived hematopoietic stem cell has not been identified and subjected to clonal analysis in a manner comparable with hematopoietic stem cells from adult bone marrow. As the chronic myeloid leukemia-associated BCR/ABL oncogene endows the adult hematopoietic stem cell with clonal dominance without inhibiting pluripotent lymphoid and myeloid differentiation, we have used BCR/ABL as a tool to enable engraftment and clonal analysis. We show that embryoid body-derived hematopoietic progenitors expressing BCR/ABL maintain a primitive hematopoietic blast stage of differentiation and generate only primitive erythroid cell types in vitro. These cells can be cloned, and when injected into irradiated adult mice, they differentiate into multiple myeloid cell types as well as T and B lymphocytes. While the injected cells express embryonic (ß-H1) globin, donor-derived erythroid cells in the recipient express only adult (ß-major) globin, suggesting that these cells undergo globin gene switching and developmental maturation in vivo. These data demonstrate that an embryonic hematopoietic stem cell arises in vitro during ES cell differentiation that constitutes a common progenitor for embryonic erythroid and definitive lymphoid-myeloid hematopoiesis.
Key words: Embryonic stem cells, Hematopoiesis, Adult reconstitution, BCR/ABL
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
T. Yamane, N. Hosen, H. Yamazaki, and I. L. Weissman Expression of AA4.1 marks lymphohematopoietic progenitors in early mouse development PNAS, June 2, 2009; 106(22): 8953 - 8958. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Jiang, E. Ng, C. Yip, W. Eisterer, Y. Chalandon, M. Stuible, A. Eaves, and C. J. Eaves Primitive interleukin 3 null hematopoietic cells transduced with BCR-ABL show accelerated loss after culture of factor-independence in vitro and leukemogenic activity in vivo Blood, November 15, 2002; 100(10): 3731 - 3740. [Abstract] [Full Text] [PDF] |
||||